Evidence map›Paper›PMID 42643381›Full record

ArticleFrontiers in nutrition2026

Development of camellia oil-based beverage and its anti-atherosclerotic effects in ApoE

Weihua Zhang, Ning Yang, Boyu Wen, Lihui Qin, Jianhui Jiang, Yifang Wang, Mei Huang, Ruichen Wang, Lili Wu, Fuan Zhang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Weihua ZhangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Ning YangSchool of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
Boyu WenSchool of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
Lihui QinGuizhou Camellia Oil Engineering Technology Research Center, Tongren, Guizhou, China.
Jianhui JiangSchool of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
Yifang WangSchool of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
Mei HuangSchool of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
Ruichen WangSchool of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
Lili WuSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Fuan ZhangGuizhou Camellia Oil Engineering Technology Research Center, Tongren, Guizhou, China.
Guozhen CuiSchool of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
Tonghua LiuSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atherosclerosis remains a leading cause of cardiovascular morbidity and mortality worldwide. Although camellia oil exhibits promising anti-atherosclerotic properties, its direct consumption is often limited by its strong flavor and greasy texture. Objective: This study aimed to develop a camellia oil-based beverage with a milky appearance, reduced greasiness, and enhanced palatability. In addition, the anti-atherosclerotic effects of the beverage were examined in ApoE Methods: A camellia oil-based oil-in-water emulsion was optimized and characterized for stability, particle size, and zeta potential. Its anti-atherosclerotic effects were evaluated in high-fat diet-fed ApoE Results and conclusion: In ApoE

Indexed as

ApoE upper position miceatherosclerosisbeveragecamellia oillipid metabolism

Identifiers

PMID42643381
PMCPMC13503217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.